1. Home
  2. WEST vs PRTC Comparison

WEST vs PRTC Comparison

Compare WEST & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westrock Coffee Company

WEST

Westrock Coffee Company

N/A

Current Price

$3.99

Market Cap

428.0M

ML Signal

N/A

Logo PureTech Health plc

PRTC

PureTech Health plc

N/A

Current Price

$16.81

Market Cap

464.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WEST
PRTC
Founded
2009
2015
Country
United States
United States
Employees
1408
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
428.0M
464.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WEST
PRTC
Price
$3.99
$16.81
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
262.3K
4.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$39.88
N/A
Revenue Next Year
$14.87
N/A
P/E Ratio
N/A
$8.09
Revenue Growth
N/A
N/A
52 Week Low
$3.59
$13.30
52 Week High
$7.92
$20.00

Technical Indicators

Market Signals
Indicator
WEST
PRTC
Relative Strength Index (RSI) 32.08 48.59
Support Level $3.95 $16.51
Resistance Level $4.67 $18.10
Average True Range (ATR) 0.21 0.49
MACD -0.11 -0.08
Stochastic Oscillator 24.81 44.66

Price Performance

Historical Comparison
WEST
PRTC

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: